Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM7R3N5)

Drug Name
Mirikizumab Drug Info
Indication
Disease Entry ICD 11 Status REF
Ulcerative colitis DD71 Approved [1]
Psoriasis vulgaris EA90 Phase 3 [2]
Cross-matching ID
TTD Drug ID
DM7R3N5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Interleukin-12 alpha (IL12A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ustekinumab DMHTYK3 Plaque psoriasis EA90.0 Approved [3]
STA-5326 DMH4C3M Crohn disease DD70 Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-12 alpha (IL12A) TTRTK6Y IL12A_HUMAN Inhibitor [2]

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761279
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
4 Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis. Arthritis Res Ther. 2008;10(5):R122.